Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.
NCT03993678
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Advanced Solid Tumors
Interventions
DRUG:
IP-001
DEVICE:
Thermal Ablation
Sponsor
Swiss Cancer Institute
Collaborators
[object Object]